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ABSTRACT. To judge a health care system, it is necessary to analyse its results in 
terms of health and to bring them back to its economic effectiveness. Health 
outcomes can be evaluated in several ways but none of them is really representative. 
To locate the performance in terms of health for the French system, we thus 
compared France with four European countries (Germany, Denmark, Sweden and 
the United-Kingdom), which are close in relation to  and comparable in terms of 
behaviour and standard of living, from 1960 to 1995. We selected a sample of 
frequent and revealing pathologies of the Health care system activity and risks 
behaviour. The result of this approach is paradoxical and sometimes in 
contradiction with the common belief, which often confuses the means and the 
results and allots the health status mainly to the action of the Health care system. 
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If various institutions, organisations or institutions have studied and 
analysed the indicators of health for several years, these works were very often 
limited to national studies with little international openings. At the French level, the 
INSERM, the HCSP or the CREDES, and on the international level WHO and 
OECD2 to quote only them, little studied the whole of health indicators available 
through international comparisons. In particular the study of France compared to 
other large industrialised countries is approached only in a limited way in the 
majority of work.  
 
It is true that the problem of the data remains particularly sensitive in this 
field. Global health indicators are indeed partial and unsatisfactory for representing 
Health status. For many years, to have an idea of population or large sample health 
status, one compared statistics of life expectancy at birth, crude death rate or infant 
death rate. Aware of these indicator borderlines to reflect such a complex variable as 
health status, the researchers in epidemiology, medicine, demography or economics 
tried to enlarge the indicators pattern to represent health status. As WHO 
information director TOMICHE [TOM 78] wrote 20 years ago : « None of existing 
indicators permit to evaluate, in a satisfactory way, increasing or decreasing 
population health status. For want of better, we currently use several partial 
indicators ». This affirmation still seems effective in spite of research efforts in that 
field. 
 
For example, the life expectancy is a very partial indicator. One can recall 
that men and women, who have the same Health care system, present a variation of 
life expectancy of 8 years in France. In fact, with time, women take less risks and 
they use more and better the supply of care. This indicator is clearly more dependant 
of socio-economic factors than care supply or the health care system. On the other 
hand, infant mortality is almost influenced by the health care system and medical 
supply (statistics of global health indicators are presented in annex). Then, global 
indicators are unsatisfactory for health measurement. 
 
Thus, several solutions were proposed. New judicious measurements to 
represent health were more or less developed like the life expectancy without 
incapacity, or certain representative specific death rates like the avoidable death rate 
or the death rate for ischaemic disease (see BRENNER [BRE 79]). In addition, 
researchers tried to approach true measurements of health by estimating this 
unobservable variable by econometric models (see VAN OF VEN & VAN DER 
                                                            
2 See end of paper for abbrevations index.  GAAG [VAN 82]). See CULYER [CUL 76], JOLY [JOL 78], MOONEY [MOO 
92], JEE & OR [JEE 99] for synthesis on health indicator problems. 
Although some information was found, these works have only reinforced the 
feeling that on a large scale, measuring exactly population health status seems more 
like a search for the Holy Grail than of a way of research leading to an admissible 
solution. 
 
Nevertheless we propose to carry out a first synthesis of the indicators by taking 
a sample of 5 European countries for several pathologies over the period 1970-1995. 
Hence, our approach is not to propose an exact measurement of health, but to try to 
give the large characteristics of the French Health care system. 
 
The objective sought in this work is obviously to bring a new angle of analysis 
of French health and some performance of our system of care such as its medicine.  
 
1. Prevention   
 
In many cases (measles, mumps, tetanus, tuberculosis), France showed a 
significant delay compared to the other countries, which tend to reabsorb. However, 
whereas diseases seem to be eradicated (rubella, measles, mumps, teeth spoiled in 
the children) at some of our neighbours (Scandinavian countries), such is not the 
case in France. 
 



















These questions were not the object of a priority of public health, nor of suitable 
financial incentives. For example, the dentists remain paid to look after the decays 
rather than to prevent them and the doctors do not receive gratification when every 
child is vaccinated. 
 The exceptional diffusion of AIDS, whose prevention was delayed, deserves to 
be pointed out.  
















On the other hand, France appears very powerful concerning the detection of  
uterus and breast cancers, dense network specialists and hospital complexes, free of 
accesses, pay-as-you-go acts, therefore encouraged the activity. However the 
priority was given to tracking, more than with the prevention. 
*: SDR = Standardised Death Rate 
















 Moreover, the resources are badly allocated since one performs too many acts of 
detection before menopause and rather afterwards. Economies and profits in human 
life could thus be increased. 
2. Pathology cures  
 
France, which was clearly late in a shocking field like maternal mortality but 
also for mortality due to current diseases like those of blood, digestive, hernias and 
obstructions of the bowels and parasitics, made up for this lost time without, 
however, filling it. 
 







































On the other hand, our delay disappeared for infant mortality, diabetes,   
cerebrovascular diseases and that known of as Hodgkin.  
 



































For mortality by appendicitis, by endocrinienne diseases and diseases of the 
respiratory system, the French evolution does not differ from the others, everyone 
having made same progress and being today appreciably on the same level.  
 
France, on the other hand, is more powerful in the processing of the elderly of  
more than 65 years and in the fight against mortality due to the circulatory system, 
cardiovascular diseases, bronchitis, asthma, etc... 
 
It seems well that these diseases were the object of detailed attention, of an 
abundant offer of specialised care. Perhaps this is what explains the excess of the 
harmful effects of the drugs and the nosocomial infections compared to the foreign 
countries. 
 
These results are connected to drug overconsumption (antibiotics and 
antidepressants in particular) and to the high number of surgical acts (appendicitis 
for example). French surgeons operate much more on appendicitis than the English 
or the Germans for comparable death rates 
 
















The fight against iatrogen risks (risks from bad health care use) is today one of 
the major goals of French public health policy in order to decrease these 
unforgivable sources of death as most of them could be avoided with better 
practising and information. 
 
 
3. Risks behaviours 
 
The excess of mortality for diseases of the liver and cirrhosis, cancers of the 
aerodigestives ways and the lung, and work and road accidents, mainly explains the 
variation of life expectancy between the men and the women, more significant in 
France. It is with alcoholism, nicotinism and the negligence of our country in front 
of the risk. 
 

















The fact of binding the rate of contribution of the companies for the industrial 
accidents to the number of accidents noted since the years 1980, if it accelerated the 
correction, was not enough to fill the unfavourable variation compared to the 
foreign countries. As much to others, this index testifies to a certain indifference of 
the French with regard to the value of the human life. 
 
Today, death rates for 20-30 year-old people have not improved in fifty years 
because of youth behaviour risks. Most of them and others can be put together in a 
special category that we call « industrial epidemics ». 
 
4. Industrial epidemics  
 
One calls " industrial epidemics ", the diseases and deaths due to products or 
behaviours risked, promoted by international industries, in general oligopolistic. 
They are for example the following elements :  
- tobacco 
- alcohol 
- speed (motor bikes and cars) 
- noise (wandering, discotheque) 
- armament (the United States) 
- violence with television 
- pollution, asbestos, mad cow...  
 
The producers call upon the will for power, the sexual image, the assertion of 
oneself or the social link to the customer, in particular, the young people. These 
producers benefit from three economic mechanisms which are favourable to them.   
Firstly, the asymmetry of information. Thanks to publicity (direct incentive), 
these industries push to take risks, badly identified with, in particular, by the young 
people. This action is reinforced by the threat to withdraw it from the media (to 
prevent the publication of the studies on the harmful effects of these risks). And, 
with respect to the public opinion, these industrialists are based on the concept of 
the personal freedoms (to smoke, go quickly, to take drugs), guaranteed by the 
constitutions or the declaration of the rights of man. 
 
Secondly, a long incubation period often separates the risk from its effects (for 
the nicotinism thirty years approximately). The production of cigarettes starts in the 
years 1910, the epidemic itself in the years 1930, the tobacco is suspected from 
1950, the causalities shown between 1960 and 1970 and the nicotinism fought from 
1980 in Anglo-Saxon countries. These deadlines tend however to decrease with 
progress of information and search.  
 
Lastly, the moral risk. The producers release from significant profits, the State 
perceives taxes without undergoing the consequences of the risks in terms of public 
health. The concept of industrial epidemics remains little recognised in France, 
although the statistics of mortality and morbidity testify to the width of their effects 
(for the road accidents) and of the delay of action (for the nicotinism or asbestos).  
 
5. Conclusion  
 
From this fast browsing of the bank of data of WHO, come out three implicit 
priorities of the system of French health: cancers, diseases cardiovascular and care 
of the elderly.  
 
On the other hand, taking into account the extravagant character of the French 
system, it seems shocking that the current diseases, childbirth and the dental decay 
was thus neglected. Lastly, the industrial epidemics remain perceived like random 
diseases, treated by remedial medicine, whereas they call a specific policy of 
prevention. These results reflect tacit arbitrations often related to mechanisms of 
remunerations or incentives. 
The French system is expensive, effective for remedial medicine, late and often 
failing for prevention. These conclusions militate for new forms of specific 
remuneration incentive to develop at the same time supply and demand of 
prevention (subscription near a general practitioner or of a dentist, capitation, 
premium with the results...). The use of indicators of performance in terms of health, 
at the regional level, in the analysis of the medical practices and the training of the 
doctors, thus, is essential.  
 
It is known that the financial constraint was felt as from 1985 in the hospitals, 
then was accentuated and generalised after 1990. However, one notes no rupture in the indicators of results (excluded maternal mortality). It thus seems that the 
improvement of the results is not related to the total equipment. 
 
Progress which remains to be made would result at the same time from a 
redeployment from the means and priorities in the system from health and actions 
determined against the risks which deteriorate the health of the young and male 
populations (nicotinism, violences, alcoholism, suicide, road accidents...). The 
doctors, in a surplus number compared to the curative needs, should play a role in 
education, information, the prevention and the modification of the individual 
attitudes (occupational medicine and school modernised). 
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WOMEN LIFE EXPECTANCY AT BIRTH 
OECD - 1960-1995 
 
                           1995 1990 1980 1970 1960
WomLife  Deviation 
Expect.  to Mean 
Rank WomLife  Deviation 
Expect.  to Mean 
Rank WomLife  Deviation 
Expect.  to Mean 
Rank WomLife  Deviation 
Expect.  to Mean 
Rank WomLife  Deviation 
Expect.  to Mean 
Rank 
Japan  82,8                          2,5 1  81,9 2,4 1  78,8 1,2 5 74,7 -0,2 13 70,2 -2,8 22
France  81,9  1,6  2  80,9  1,4  2  78,4  0,8  9  75,9  1,0  8  73,6  0,6  11 
Switzerland  81,7                              1,4 3 80,9 1,4 3 78,8 1,2 7 76,2 1,3 6 74,1 1,1 8
Sweden  81,5                              1,2 4 80,4 0,9 6 78,8 1,2 6 77,1 2,2 2 74,9 1,9 4
Canada  81,3                              1,0 5 80,4 0,9 4 79,1 1,5 4 76,4 1,5 4 74,3 1,3 5
Spain  81,2                              0,7 6 80,4 0,9 5 78,6 1,0 8 75,1 0,2 10 72,2 -0,8 16
Australia  80,9                              0,6 7 80,1 0,6 8 78,1 0,5 10 74,2 -0,7 15 73,9 0,9 9
Italy  80,8                              0,5 8 80 0,5 10 77,4 -0,2 14 74,9 0,0 11 72,3 -0,7 15
Norway  80,8                          0,5 9 79,8 0,3 11 79,2 1,6 2 77,3 2,4 1  75,8 2,8 1 
Iceland  80,6                            0,3 10 80,3 0,8 7 79,7 2,1 1  76,3 1,4 5 75 2,0 3
Netherlands  80,4                              0,1 11 80,1 0,6 9 79,2 1,6 3 76,6 1,7 3 75,5 2,5 2
Greece  80,3                              0,0 12 79,4 -0,0 12 76,6 -1,0 17 73,6 -1,3 20 70,7 -2,3 21
Finland  80,2                              -0,1 13 78,9 -0,6 16 77,6 0,0 12 74,2 -0,7 17 71,6 -1,4 20
Austria  80,1                              -0,2 14 78,9 -0,6 15 76,1 -1,5 20 73,4 -1,5 21 71,9 -1,1 17
Belgium  80,0                              -0,3 15 79,1 -0,4 14 76,8 -0,8 15 74,2 -0,7 16 73,5 0,5 12
United-Kingdom  79,7                              -0,6 16 78,6 -0,9 18 75,9 -1,7 21 75,2 0,3 9 74,2 1,2 6
Luxembourg  79,5                              -0,8 17 78,5 -1,0 19 75,1 -2,5 22 73,9 -1,0 18 71,9 -1,1 18
Germany  79,5                              -0,8 18 79,1 -0,4 13 76,6 -1,0 16 73,8 -1,1 19 72,4 -0,6 14
New-Zealand  79,2                              -1,1 19 78,3 -1,2 20 76,3 -1,3 19 74,6 -0,3 14 73,9 0,9 10
United States  79,2                              -1,1 20 78,8 -0,7 17 77,4 -0,2 13 74,7 -0,2 12 73,1 0,1 13
Portugal  78,6                              -1,7 21 77,9 -1,6 21 76,6 -1,0 18 71 -3,9 23 67,2 -5,8 23
Ireland  78,5                              -1,8 22 77,5 -2,0 23 75 -2,6 23 73,2 -1,7 22 71,8 -1,2 19
Denmark  77,8                              -2,5 23 77,7 -1,8 22 77,6 0,0 11 75,9 1,0 7 74,1 1,1 7
Mean                 80,3  79,5  77,6  74,9  73,0 
Stand.deviation                   1,20 1,14  1,37  1,47  1,95 
Growth rate  0,86                 2,49  3,46  2,51  - 
         
 
  12 Source OECD-CREDES : Health Data 1997 
MEN LIFE EXPECTANCY AT BIRTH 
OECD - 1960-1995 
 





Rank Men  Life
Expect. 
  Deviation 
to Mean 
Rank Men  Life
Expect. 
  Deviation 
to Mean 
Rank Men  Life
Expect. 
  Deviation 
to Mean 
Rank Men  Life
Expect. 
  Deviation 
to Mean 
Rank 
Iceland  76,5                          2,4 1  75,7 2,6 2 73,7 2,9 1  71,1 2,4 2 70,7 2,8 5
Japan  76,4                            2,3 2 75,9 2,8 1  73,4 2,6 2 69,3 0,6 10 65,3 -2,6 21
Sweden  76,2                            2,1 3 74,8 1,7 3 72,8 2,0 3 72,2 3,5 1  71,2 3,3 4
Switzerland  75,3                              1,2 4 74,0 0,9 5 72,3 1,5 7 70,3 1,6 6 68,7 0,8 7
Canada  75,3                              1,2 5 73,8 0,7 7 71,9 1,1 9 69,3 0,6 9 68,4 0,5 9
Greece  75,1                              1,0 6 74,6 1,5 4 72,2 1,4 8 70,1 1,4 7 67,5 -0,4 13
Australia  75,0                              0,9 7 73,9 0,8 6 71,0 0,2 11 67,4 -1,3 18 67,9 0,0 11
Norway  74,8                              0,7 8 73,4 0,3 11 72,3 1,5 6 71,0 2,3 3 71,3 3,4 3
Netherlands  74,6                              0,5 9 73,8 0,7 8 72,4 1,6 5 70,9 2,2 4 71,6 3,7 2
Italy  74,4                              0,3 10 73,5 0,4 9 70,6 -0,2 12 69,0 0,3 11 67,2 -0,7 15
United-Kingdom  74,3                              0,2 11 72,9 -0,2 12 70,2 -0,6 14 68,6 -0,1 12 68,3 0,4 10
France  73,9  -0,2  12  72,7  -0,4  14  70,2  -0,6  13  68,4  -0,3  14  67,0  -0,9  16 
New-Zealand  73,8                              -0,3 13 72,4 -0,7 17 70,1 -0,7 15 68,3 -0,4 15 68,7 0,8 6
Austria  73,5                              -0,6 14 72,4 -0,7 15 69,0 -1,8 21 66,5 -2,2 21 65,4 -2,5 20
Belgium  73,3                              -0,8 15 72,4 -0,7 16 70,0 -0,8 16 67,8 -0,9 16 67,7 -0,2 12
Spain  73,2                              -0,9 16 73,4 0,7 10 72,5 1,7 4 69,6 0,9 8 67,4 -0,5 14
Germany  73,0                              -1,1 17 72,7 -0,4 13 69,9 -0,9 18 67,4 -1,3 17 66,9 -1,0 17
Ireland  72,9                              -1,2 18 72,0 -1,1 20 69,5 -1,3 19 68,5 -0,2 13 68,5 0,6 8
Finland  72,8                              -1,3 19 70,9 -2,2 22 69,2 -1,6 20 65,9 -2,8 22 64,9 -3,0 22
Denmark  72,5                            -1,6 20 72,0 -1,1 19 71,4 0,6 10 70,7 2,0 5 72,3 4,4 1 
United States  72,5                              -1,6 21 71,8 -1,3 21 70,0 -0,8 17 67,1 -1,6 19 66,6 -1,3 18
Luxembourg  72,5                              -1,6 22 72,3 -0,8 18 68,0 -2,8 22 67,0 -1,7 20 66,1 -1,8 19
Portugal  71,5                              -2,6 23 70,9 -2,2 23 67,7 -3,1 23 65,3 -3,4 23 61,7 -6,8 23
Mean                   74,1 73,1  70,8  68,7  67,9 
Stand.deviation                   1,38 1,33  1,66  1,81  2,46 
Growth rate  1,31                 3,18  3,07  1,31  - 
           
 
Source OECD-CREDES : Health Data 1997 
  13 INFANT MORTALITY 
OECD - 1960-1995 
 






















Finland  0,40                        -0,18 1  0,56 -0,21 2 0,76 -0,41 3 1,32 -0,73 5 2,10 -0,80 6
Norway  0,40                              -0,18 2 0,70 -0,07 7 0,81 -0,36 5 1,27 -0,78 2 1,89 -1,01 4
Sweden  0,41                          -0,17 3 0,60 -0,17 4 0,69 -0,48 1  1,10 -0,95 1  1,66 -1,24 2
Japan  0,43                            -0,15 4 0,46 -0,31 1  0,75 -0,42 2 1,31 -0,74 4 3,07 0,17 15
Switzerland  0,50                              -0,08 5 0,68 -0,09 6 0,91 -0,26 8 1,51 -0,54 8 2,11 -0,79 7
Luxembourg  0,50                              -0,08 6 0,74 -0,03 11 1,15 -0,02 13 2,49 0,44 18 3,15 0,25 17
France  0,50  -0,08  7  0,73  -0,04  10  1,00  -0,17  9  1,82  -0,23  11  2,74  -0,16  13 
Germany  0,53                              -0,05 8 0,71 -0,06 8 1,27 0,10 18 2,34 0,29 17 3,38 0,48 18
Austria  0,54                              -0,04 9 0,78 0,01 14 1,43 0,26 20 2,59 0,54 19 3,75 0,85 19
Denmark  0,55                              -0,03 10 0,75 -0,02 12 0,84 -0,33 6 1,42 -0,63 7 2,15 -0,75 8
Netherlands  0,55                              -0,03 11 0,71 -0,06 9 0,86 -0,31 7 1,27 -0,78 3 1,79 -1,11 3
Spain  0,55                              -0,03 12 0,76 -0,01 13 1,23 0,06 16 2,63 0,58 20 4,37 1,47 21
Australia  0,57                              -0,01 13 0,82 0,05 17 1,07 -0,10 11 1,79 -0,26 10 2,02 -0,88 5
United-Kingdom  0,60                              0,02 14 0,79 0,02 15 1,21 0,04 15 1,85 -0,20 12 2,25 -0,65 9
Canada  0,60                              0,02 15 0,68 -0,09 5 1,04 -0,13 10 1,88 -0,17 13 2,73 -0,17 12
Iceland  0,61                          0,03 16  0,59 -0,18 3 0,77 -0,40 4 1,32 -0,73 6 1,30 -1,60 1 
Italy  0,62                              0,04 17 0,82 0,05 19 1,46 0,29 21 2,96 0,91 21 4,39 1,49 22
Ireland  0,63                              0,05 18 0,82 0,05 18 1,11 -0,06 12 1,95 -0,10 14 2,93 0,03 14
New-Zealand  0,70                              0,12 19 0,84 0,07 20 1,29 0,12 19 1,68 -0,37 9 2,26 -0,64 10
Belgium  0,70                              0,12 20 0,80 0,03 16 1,21 0,04 14 2,11 0,06 16 3,12 0,22 16
Portugal  0,74                              0,16 21 1,10 0,33 23 2,43 1,26 23 5,51 3,46 23 7,75 4,85 23
United States  0,80                              0,22 22 0,92 0,15 21 1,26 0,09 17 2,00 -0,05 15 2,60 -0,30 11
Greece  0,81                              0,23 23 0,97 0,20 22 1,79 0,62 22 2,96 0,91 21 4,01 1,11 20
Mean                           0,61 0,77 1,15 2,05 2,94
Stand.deviation                           0,12 0,14 0,39 0,94 1,35
Growth rate                            -22,2 -34,3 -42,9 -29,4
                   
 
Source OECD-CREDES : Health Data 1997 
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CRUDE DEATH RATES 
OECD - 1960-1994 
 
 























Iceland  6,5  1  3,1                    6,7 1  2,9 6,7 2 3,1 7,1 2 3,0 6,6 1  3,2 
Japan  7,0                        2 2,6 6,7 1  2,9 6,2 1  3,6 6,9 1  3,2 7,6 4 2,2
Australia  7,1                              3 2,5 7,0 3 2,6 7,4 4 2,4 8,9 8 1,2 8,5 6 1,3
Canada  7,2                              4 2,4 7,2 4 2,4 7,2 3 2,6 7,3 3 2,8 7,8 5 2,0
New-Zealand  7,7                              5 1,9 7,9 5 1,7 8,5 7 1,3 8,8 7 1,3 8,8 8 1,0
Spain  8,6                              6 1,0 8,6 6 1,0 7,7 5 2,1 8,4 6 1,7 8,6 7 1,2
Ireland  8,6                              7 1,0 8,9 9 0,7 9,8 12 0,0 11,4 18 -1,3 11,5 19 -1,7
Netherlands  8,7                              8 0,9 8,6 7 1,0 8,0 6 1,8 8,4 5 1,7 7,5 3 2,3
United States  8,8                              9 0,8 8,6 8 1,0 8,8 8 1,0 9,5 10 0,6 9,5 11 0,3
Switzerland  8,9                              10 0,7 9,5 12 0,1 9,4 11 0,4 9,2 9 0,9 9,8 15 0,0
France  9,0  11  0,6  9,4  11  0,2  10,1  16  -0,3  10,6  17  -0,5  11,3  18  -1,5 
Greece  9,4                              12 0,2 9,3 10 0,3 9,1 9 0,7 8,4 4 1,7 7,3 2 2,5
Finland  9,4                              13 0,2 10,0 15 -0,4 9,2 10 0,6 9,6 11 0,5 9,0 9 0,8
Italy  9,6                              14 0,0 9,5 13 0,1 9,9 13 -0,1 9,8 13 0,3 9,6 13 0,2
Luxembourg  9,8                              15 -0,2 9,9 14 -0,3 11,2 19 -1,4 12,4 22 -2,3 11,8 22 -2,0
Portugal  10,0                              16 -0,4 10,4 16 -0,8 9,9 14 -0,1 10,3 16 -0,2 10,5 17 -0,7
Austria  10,0                              17 -0,4 10,7 18 -1,1 12,2 23 -2,4 13,2 24 -3,1 12,7 24 -2,9
Norway  10,2                              18 -0,6 10,9 19 -1,3 10,1 15 -0,3 10,0 14 0,1 9,2 10 0,6
Sweden  10,5                              19 -0,9 11,1 20 -1,5 11,1 18 -1,3 10,0 15 0,1 10,0 16 -0,2
Belgium  10,7                              20 -1,1 10,5 17 -0,9 11,5 20 -1,7 12,3 21 -2,2 12,4 23 -2,6
Germany  11,0                              21 -1,4 11,3 22 -1,7 11,6 21 -1,8 12,1 20 -2,0 11,6 21 -1,8
United-Kingdom  11,3                              22 -1,7 11,2 21 -1,6 11,8 22 -2,0 11,7 19 -1,6 11,5 20 -1,7
Czech Rep.  11,4                              23 -1,8 12,5 24 -2,9 13,1 24 -3,3 12,6 23 -2,5 9,7 14 0,1
Denmark  11,8                              24 -2,2 11,9 23 -2,3 10,9 17 -1,1 9,7 12 0,4 9,6 12 0,2
MEAN                     9,4 9,6  9,8  9,8
                     
For United-Kingdom and Luxembourg 1993 data for 1994 
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STANDARDIZED DEATH RATES 
OECD - 1960-1993 
 
 























Japan  5,9  1  1,7                        6,2 1  1,7 7,9 2 1,4 10,8 13 0,0 13,2 22 -1,8
Iceland  6,5                        2 1,1 6,8 2 1,1 7,4 1  1,9 9,2 3 1,6 8,8 1  2,6 
Switzerland  6,6                              3 1,0 7,1 4 0,8 8,2 5 1,1 9,9 9 0,9 11,1 9 0,3
France  6,7  4  0,9  6,9  3  1,0  8,5  10  0,8  9,7  7  1,1  11,4  12  0,0 
Australia  6,7                              5 0,9 7,2 7 0,7 8,9 12 0,4 11,7 17 -0,9 11,4 10 0,0
Canada  6,8                              6 0,8 7,1 6 0,8 8,3 9 1,0 9,8 8 1,0 11,1 7 0,3
Sweden  6,9                              7 0,7 7,1 5 0,8 8,3 8 1,0 8,8 2 2,0 10,2 5 1,2
Spain  7                              8 0,6 7,4 8 0,5 8,2 6 1,1 10,4 10 0,4 11,4 11 0,0
Italy  7,1                              9 0,5 7,4 10 0,5 9,1 13 0,2 10,4 11 0,4 11,6 16 -0,2
Greece  7,2                            10 0,4 7,4 9 0,5 8,3 7 1,0 8,8 1  2,0 10,0 4 1,4
Norway  7,5                              11 0,1 7,7 12 0,2 8,2 4 1,1 9,3 4 1,5 9,5 2 1,9
Netherlands  7,6                              12 0,0 7,5 11 0,4 8,1 3 1,2 9,6 5 1,2 9,7 3 1,7
United States  7,7                              13 -0,1 8,0 13 -0,1 8,9 11 0,4 10,8 12 0,0 11,6 15 -0,2
Austria  7,8                              14 -0,2 8,1 15 -0,2 10,2 19 -0,9 12,1 20 -1,3 12,5 19 -1,1
New-Zealand  7,8                              15 -0,2 8,1 16 -0,2 10,3 20 -1,0 11,4 15 -0,6 11,1 8 0,3
United-Kingdom  7,9                              16 -0,3 8,2 17 -0,3 9,8 17 -0,5 11,0 14 -0,2 11,4 13 0,0
Germany  8,0                              17 -0,4 8,1 14 -0,2 9,6 15 -0,3 11,7 18 -0,9 12,7 20 -1,3
Belgium  8                              18 -0,4 8,2 18 -0,3 10,0 18 -0,7 11,5 16 -0,7 12,4 18 -1,0
Luxembourg  8,0                              19 -0,4 8,4 19 -0,5 10,7 21 -1,4 12,2 21 -1,4 12,7 21 -1,3
Finland  8,3                              20 -0,7 8,7 21 -0,8 9,7 16 -0,4 12,5 22 -1,7 13,3 24 -1,9
Denmark  8,7             14                21 -1,1 8,7 20 -0,8 9,2 0,1 9,6 6 1,2 10,6 6 0,8
Ireland  8,8                              22 -1,2 9,3 22 -1,4 11,0 22 -1,7 12,1 19 -1,3 12,1 17 -0,7
Portugal  9,3                              23 -1,7 9,3 23 -1,4 11,2 23 -1,9 12,6 23 -1,8 13,2 23 -1,8
Czech Rep.  10,5                              24 -2,9 11,7 24 -3,8 12,5 24 -3,2 12,8 24 -2,0 11,5 14 -0,1
Mean                 7,6  7,9  9,3  10,8  11,4 
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PYLL (POTENTIAL YEARS OF LIFE LOST) FOR 100 000 WOMEN 



























Japan  2622,6  1  927,2                        2666,5 1  1106,1 3644,3 3 1147,8 6028,1 9 614,0 10705,7 23 -2554,3
Austria  2711,0                              2 838,8 2782,0 2 990,6 4413,9 9 378,2 6460,1 11 182,0 7984,2 15 167,2
Sweden  2913,5                              3 636,3 3150,1 3 622,5 3713,8 4 1078,3 4584,8 2 2057,3 5915,0 4 2236,4
Iceland  3011,6                      4 538,2 3353,5 5 419,1 3270,7 1  1521,4 4519,0 1  2123,1 5561,6 1  2589,8 
Switzerland  3149,1                              5 400,7 3292,1 4 480,5 3842,9 6 949,2 5343,6 5 1298,5 6674,4 5 1477,0
Spain*  3150                              6 399,8 3453,5 9 319,1 4370,6 8 421,5 6430,5 10 211,6 9745,4 21 -1594,0
Norway  3205,4                              7 344,4 3379,7 6 392,9 3624,1 2 1168,0 4607,6 3 2034,5 5816,5 2 2334,9
Finland  3265,1                              8 284,7 3481,8 10 290,8 3775,4 5 1016,7 5683,8 7 958,3 7489,5 11 661,9
France  3334,4  9  215,4  3448,6  8  324,0  4520,7  10  271,4  5899,1  8  743,0  7505,2  12  646,2 
Italy  3376,0                              10 173,8 3382,6 7 390,0 4851,9 14 -59,8 7599,1 20 -957,0 10544,2 22 -2392,8
Australia  3391,9                              11 157,9 3619,7 12 152,9 4714,2 11 77,9 6960,8 15 -318,7 7477,5 10 673,9
Netherlands  3411,0                              12 138,8 3491,9 11 280,7 3938,4 7 853,7 5227,5 4 1414,6 5861,9 3 2289,5
Canada  3413,0                              13 136,8 3668,3 14 104,3 4801,1 12 -9,0 6499,7 13 142,4 7979,1 14 172,3
Greece  3421,4                              14 128,4 3627,0 13 145,6 4924,0 15 -131,9 6986,1 16 -344,0 8124,4 16 27,0
Luxembourg  3484,0                              15 65,8 4204,0 19 -431,4 5841,6 21 -1049,5 8059,9 23 -1417,8 6807,3 7 1344,1
Belgium*  3600                              16 -50,2 3850 16 -77,4 5155,2 17 -363,1 6808,8 14 -166,7 8278,7 17 -127,3
Germany  3669,6                              17 -119,8 3695,0 15 77,6 5071,5 16 -279,4 7282,8 19 -640,7 8889,4 19 -738,0
United-Kingdom  3762,3                              18 -212,5 4056,8 17 -284,2 5259,9 18 -467,8 6462,6 12 179,5 7176,9 8 974,5
Ireland  3835,8                              19 -286,0 4146,0 18 -373,4 5439,5 19 -647,4 7629,0 21 -986,9 9251,9 20 -1100,5
Denmark  4214,4                              20 -664,6 4450,5 20 -677,9 4826,7 13 -34,6 5616,5 6 1025,6 6696,0 6 1455,4
New-Zealand  4240,8                              21 -691,0 4680,6 21 -908,0 6136,0 22 -1343,9 7039,0 17 -396,9 7710,1 13 441,3
Portugal  4582,6                              22 -1032,8 4884,1 23 -1111,5 6970,5 24 -2178,4 12822,0 24 -6179,9 17396,1 24 -9244,7
United States  4656,1                              23 -1106,3 4816,9 22 -1044,3 5715,0 20 -922,9 7697,5 22 -1055,4 8658,4 18 -507,0
Czech Rep.  4773,1                              24 -1223,3 4960,2 24 -1187,6 6189,2 23 -1397,1 7162,4 18 -520,3 7384,0 9 767,4
Mean               3549,8   3772,6    4792,1    6642,1    8151,4 
 
Source OECD-CREDES : Health Data 1997 
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PYLL (POTENTIAL YEARS OF LIFE LOST) FOR 100 000 MEN 




























Iceland  4377,4  1  2203,0                          5396,5 4 1513,8 7621,1 6 1060,1 9891,7 7 1329,2 9373,2 4 2954,2
Japan  4792,8                          2 1787,6 4917,8 1  1992,5 6298,9 1  2382,3 9811,3 6 1409,6 14785,3 22 -2457,9
Sweden  4878,8                        3 1701,6 5270,5 2 1639,8 6585,3 2 2095,9 7389,9 1  3831,0 8470,2 1  3857,2 
Austria  5242,0                              4 1338,4 5347,0 3 1563,3 8727,0 13 -45,8 11724,4 16 -503,5 12973,5 16 -646,1
Netherlands  5421,1                              5 1159,3 5752,8 5 1157,5 6982,9 3 1698,3 8910,8 3 2310,1 8907,9 2 3419,5
Norway  5673,7                              6 906,7 6195,6 6 714,7 7319,8 5 1361,4 8989,3 4 2231,6 9431,1 5 2896,3
Australia  5743,6                              7 836,8 6197,5 7 712,8 8589,9 11 91,3 11847,6 17 -626,7 11804,7 11 522,7
Canada  5789,1                              8 791,3 6384,3 9 526,0 8608,2 12 73,0 11016,8 13 204,1 12601,1 15 -273,7
United-Kingdom  5941,1                              9 639,3 6496,8 11 413,5 8442,0 10 239,2 10380,3 9 840,6 11319,0 9 1008,4
Switzerland  6087,5                              10 492,9 6224,2 8 686,1 7094,0 4 1587,2 9403,3 5 1817,6 11052,8 8 1274,6
Ireland  6196,0                              11 384,4 6639,0 12 271,3 8941,1 15 -259,9 10938,3 12 282,6 12131,0 13 196,4
Greece  6408,9                              12 171,5 6458,1 10 452,2 8064,2 8 617,0 10271,8 8 949,1 10352,3 6 1975,1
Belgium  6600                              13 -19,6 6900 15 10,3 9221,2 19 -540,0 11635,5 15 -414,6 13630,8 18 -1303,4
Denmark  6623,1                              14 -42,7 6953,5 16 -43,2 7623,7 7 1057,5 8749,8 2 2471,1 9334,9 3 2992,5
Italy  6699,9                              15 -119,5 6667,7 13 242,6 8971,4 16 -290,2 12022,6 18 -801,7 14939,8 23 -2612,4
Finland  6948,8                              16 -368,4 7610,5 20 -700,2 9014,4 17 -333,2 12680,8 20 -1459,9 14040,0 20 -1712,6
Germany  7035,6                              17 -455,2 6808,2 14 102,1 9171,7 18 -490,5 12205,4 19 -984,5 13653,4 19 -1326,0
New-Zealand  7066,6                              18 -486,2 7417,0 18 -506,7 9226,7 20 -545,5 11437,9 14 -217,0 11406,4 10 921,0
Spain  7200                              19 -619,6 7603,0 19 -692,7 8130,7 9 550,5 10481,4 10 739,5 13561,0 17 -1233,6
Luxembourg  7356,5                              20 -776,1 7376,7 17 -466,4 8753,6 14 -72,4 13728,2 23 -2507,3 10416,1 7 1911,3
France  7378,3  21  -797,9  7623,9  21  -713,6  9360,9  21  -679,7  10886,7  11  334,2  12469,9  14  -142,5 
United States  8503,9                              22 -1923,5 8791,2 22 -1880,9 10300,4 22 -1619,2 13479,2 22 -2258,3 14158,3 21 -1830,9
Portugal  9915,4                              23 -3335,0 9919,9 23 -3009,6 13201,4 24 -4520,2 18676,8 24 -7455,9 23073,6 24 -10746,2
Czech Rep.  10048,8                              24 -3468,4 10896,2 24 -3985,9 12097,4 23 -3416,2 12740,8 21 -1519,9 11970,7 12 356,7
Mean                 6580,4  6910,3  8681,2  11220,9  12327,4 
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GLOBAL HEALTH OUTCOMES 
 





  Life Expectancy  
at birth for Women 
(in years) 
Life Expectancy  
at birth for Men 
(in years) 
Potential Years of Life Lost 
(PYLL)  for  
100 000 Women* 
Potential Years of Life Lost 
(PYLL)  for  
100 000 Men* 
Global Standardised Death 
Rate for 
1 000 people ** 
Infant Mortality  
Rate for 100 births 
 
  Data                        Rank Data Rank Data Rank Data Rank Data Rank Data Rank
Sweden  81,5                            4 76,2 3 2 914 3 4 879 3 6,9 7 0,41 3
France  81,9  2  73,9  12  3 334  9  7 378  21  6,7  4  0,50  7 
Italy  80,8                            8 74,4 10 3 376 10 6 700 15 7,1 9 0,62 17
Unit-Kingdom  79,7                            16 74,3 11 3 762 18 5 941 9 7,9 16 0,60 14
Germany  79,5                            18 73,0 17 3 670 17 7 036 17 8,0 17 0,53 8
Denmark  77,8                            23 72,5 20 4 214 20 6 623 14 8,7 21 0,55 10
Source OECD - CREDES : : Health Data 1997 
* : 1992 data 




  Life Expectancy  
at birth for Women 
(in years) 
Life Expectancy  
at birth for Men 
(in years) 
Potential Years of Life Lost 
(PYLL)  for  
100 000 Women* 
Potential Years of Life Lost 
(PYLL)  for  
100 000 Men* 
Global Standardised Death 
Rate for 
1 000 people ** 
Infant Mortality  
Rate for 100 births 
 
  Data                        Rank Data Rank Data Rank Data Rank Data Rank Data Rank
Sweden  74,9                            4 71,2 4 5 915 4 8 470 1 10,2 5 1,66 2
Denmark  74,1                            7 72,3 1 6 696 6 9 334 3 10,6 6 2,15 9
Unit-Kingdom  74,2                            6 68,3 10 7 177 8 11 319 9 11,4 12 2,25 10
France  73,6  11  67,0  17  7 505  12  12 470  14  11,4  12  2,74  14 
Germany  72,4                            15 66,9 18 8 889 19 13 653 19 12,7 20 3,38 19
Italy  72,3                            16 67,2 16 10 544 22 14 940 23 11,6 16 4,39 23
Source OECD - CREDES : : Health Data 1997 
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